Table 1.
n | % | |
---|---|---|
Median age, 30 (16–59) years | ||
Age > 50 years | 4 | 5 |
Gender | ||
Male | 44 | |
Female | 43 | |
Subtype of classical HL | ||
Nodular sclerosis | 73 | 84 |
Mixed cellularity | 14 | 16 |
Stage | ||
IA | 23 | 26 |
IIA or IIEA | 64 | 74 |
ESR ≥ 50 mm/h | 12 | 14 |
Mediastinal involvement | 65 | 75 |
Ann Arbor nodal sites > 3 | 16 | 18 |
Ann Arbor nodal sites > 2 | 39 | 45 |
Extranodal disease | 3 | 3 |
Unfavorable risk factors | ||
GHSG criteria | ||
>2 nodal regionsa, ESR ≥ 50, E sites | 42 | 48 |
EORTC criteria | ||
>3 nodal regionsb, ESR ≥ 50, mixed cellularity, age > 50 years | 33 | 38 |
aDefined according to GHSG criteria.
bDefined according to EORTC criteria.
ESR, erythrocyte sedimentation rate; GHSG, German Hodgkin Study Group; EORTC, European Organisation for Research and Treatment of Cancer.